Verma D D, Verma S, Blume G, Fahr A
Institut für Pharmazeutische Technologie und Biopharmazie, Philipps-Universität Marburg, Ketzerbach 63, 35037, Marburg, Germany.
Int J Pharm. 2003 Jun 4;258(1-2):141-51. doi: 10.1016/s0378-5173(03)00183-2.
In the present study, the influence of vesicle size on the penetration of two fluorescently labeled substances into the human skin was investigated. For the measurements either a hydrophilic fluorescent compound [carboxyfluorescein (CF)] or a lipophilic one [1,1'-dioctadecyl-3,3,3',3'-tertramethylindocarbo-cyanine perchlorate (DiI)] were encapsulated into vesicles. Liposomal formulations were prepared by extruding the vesicles through polycarbonate membrane filters with pores of different sizes. In vitro penetration studies into human abdominal skin were performed by using the Franz diffusion cell and a standardized skin stripping technique in attempt to find an optimum size for topical drug delivery by liposomes. Confocal laser scanning microscopy (CLSM) was used to visualize the effect of penetration ability of liposomal DiI. The maximum DiI fluorescence in the skin was observed with smaller liposomes of 71 nm diameter. The liposomes with a size of 120 nm diameter showed statistically enhanced penetration of CF into the skin as compared to larger ones. The results indicated that the CF penetration was inversely related to the size of the liposomes, which was confirmed by the data of the confocal laser scanning microscopy studies.
在本研究中,研究了囊泡大小对两种荧光标记物质渗透入人体皮肤的影响。为了进行测量,将一种亲水性荧光化合物[羧基荧光素(CF)]或一种亲脂性化合物[1,1'-二辛基-3,3,3',3'-四甲基吲哚碳菁高氯酸盐(DiI)]包裹到囊泡中。通过将囊泡挤压通过具有不同孔径的聚碳酸酯膜过滤器来制备脂质体制剂。使用Franz扩散池和标准化的皮肤剥离技术对人体腹部皮肤进行体外渗透研究,试图找到脂质体用于局部给药的最佳尺寸。共聚焦激光扫描显微镜(CLSM)用于观察脂质体DiI的渗透能力的效果。在直径为71nm的较小脂质体中观察到皮肤中DiI的最大荧光。与较大尺寸的脂质体相比,直径为120nm的脂质体显示CF在皮肤中的渗透在统计学上增强。结果表明CF的渗透与脂质体的大小呈负相关,这通过共聚焦激光扫描显微镜研究的数据得到证实。